Member Info for volcano

AFC Energy PLCAFC:LSE
Average volume 13.02m
Shares outstanding 676.15m
Free float 622.28m
P/E (TTM) --

out of auction ,
64.90 GBX +6.70 (11.51%)
24 Dec, 09:02 GMT · Disclaimer

WAIT FOR IT! EUROPEAN STOCKS KEEP THEIR COOL (0824 GMT)

European bourses, at least the ones open today such as
London, Paris and Madrid, are rising in early trading - but
quite cautiously.

All eyes are on a press conference, which had been expected
around now but has been delayed a little, and investors seem to
be waiting for an official Brexit trade deal announcement to go
any further.

British midcaps, a soft Brexit play, are rising over 1% on
the FTSE 250 and back to February highs.

The fact that Lloyds is the best performer of the FTSE 100
is no surprise: the UK focused bank has long been identified as
a stock which would benefit from a EU/UK deal

What Is an Auction Market? In an auction market, buyers enter competitive bids and sellers submit competitive offers at the same time. The price at which a stock trades represents the highest price that a buyer is willing to pay and the lowest price that a seller is willing to accept

37.14 GBX +2.44 (7.04%)
23 Dec, 16:30 GMT · Disclaimer
it will be better tomorrow ,have a wee-faith

Man Group PLC
EMG
139.05 GBX
+3.55 (2.62%)
nice and steady but it is up 30% in few weeks, not bad at all.

The AstraZeneca coronavirus vaccine could be approved by regulators just after Christmas, according to a medical scientist.

Professor Sir John Bell said he expects the vaccine - which has been developed by Oxford University researchers - to get the green light "pretty shortly".

He told the Today programme that the Medicines and Healthcare products Regulatory Agency (MHRA) has received "multiple sets of data" about the vaccine.

"So we are getting to be about prime time now, I would expect some news pretty shortly," he added.

"I doubt we'll make Christmas now, but just after Christmas I would expect.

"I have no concerns whatsoever that the data looks better than ever."

The government has ordered 100 million doses of the Oxford/AstraZeneca vaccine, with around 40 million to be made available by the end of March.

Approval of the vaccine would help boost the UK's battle against Covid-19 as it is easier to distribute than the Pfizer/BioNTech jab - which is currently being administered to certain groups across the UK.

223.22 GBX +57.32 (34.55%)

it is a miracle after few miserable days CPI is finishing the day on blue , hallelujah

better later than ever ,lol

it is like a tango , lol

One Step Forward, Two Steps Back

every time MM lower the price before US opens , we do bend backwards to please them, lol

eatstocks i hope so mate ,i am still under water with CPI.

EMG is doing better than most companies out there ,
EMG 132.05 -1.05 -0.79%

MTRO 131.70 +16.90 +14.72%
just opened

never read the after hours news, lol ,
not trading yet

i thought MTRO would have issue a RNS for this, maybe later

Could you tell us Why Brexit will effect CPI.

looks like we are heading for the twenties anyway

this was posted by Paul Scott on 16/12/20 , looks like he was right ,so far

Capita (LON:CPI)
43p - mkt cap £720m

This complex, low margin outsourcing group briefly dipped into small cap territory in October, but along with many other bombed out shares, bounced strongly in November on positive vaccine news, in what fund manager Keith Ashworth-Lord recently described as a “dash for trash”!

I want to follow up on it, because I covered Capita’s Q3 trading update here on 10 Nov 2020, and was quite shocked at how weak its balance sheet is - one of the worst I’ve seen, with NTAV negative at £(1.6)bn. Therefore a large equity fundraising will be needed at some point - hence shareholders are hostages to that being done on reasonable terms. If it’s bungled, and results in large dilution, then that could damage existing shareholders. Why take that risk?